Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,037,646
in 4 filings

Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-22 BUTITTA CYNTHIA M Director Grant or award · Restricted Stock Unit +8,000 8,000
2026-06-22 WEN LEANA Director Grant or award · Stock Option (right ot buy) +10,000 10,000
2026-06-22 WEN LEANA Director Grant or award · Restricted Stock Unit +8,000 8,000
2026-06-22 Belldegrun Arie Director Grant or award · Stock Option (right ot buy) +20,000 20,000
2026-06-08 Schoenberg Mark Chief Medical Officer Option exercise +10,000 144,985
2026-06-08 Schoenberg Mark Chief Medical Officer Sale −5,222 $27.30 $143K 139,763
2026-06-08 Schoenberg Mark Chief Medical Officer Option exercise · Restricted Stock Units −10,000 0
2026-05-26 Robinson James A. Jr. Director Option exercise +2,000 6,000
2026-05-26 Robinson James A. Jr. Director Option exercise · Restricted Stock Unit −2,000 2,000
2026-05-08 Schoenberg Mark Chief Medical Officer Sale 10b5-1 −10,000 $30.00 $300K 134,985
2026-02-03 Smith Jason Drew General Counsel Sale −2,654 $19.69 $52K 52,934
2026-02-03 Smith Jason Drew General Counsel Sale −1,608 $19.69 $32K 51,326
2026-02-03 Smith Jason Drew General Counsel Sale −3,217 $19.69 $63K 55,588
2026-02-03 Schoenberg Mark Chief Medical Officer Sale −1,844 $19.69 $36K 150,514
2026-02-03 Schoenberg Mark Chief Medical Officer Sale −1,843 $19.69 $36K 148,671
2026-02-03 Schoenberg Mark Chief Medical Officer Sale −3,686 $19.69 $73K 144,985
2026-01-31 Barrett Elizabeth A. Chief Executive Officer Grant or award · Restricted Stock Units +153,195 153,195
2026-01-31 Smith Jason Drew General Counsel Option exercise +5,500 55,472
2026-01-31 Smith Jason Drew General Counsel Option exercise +3,333 58,805
2026-01-31 Smith Jason Drew General Counsel Option exercise +6,667 49,972

Page 2 of 13 · 244 trades